Skip to main content
SpringerLink
Log in

Role of C-reactive protein, D-dimer, and fibrinogen levels in the differential diagnosis of central and peripheral vertigo

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Vertigo is encountered frequently in emergency services. Researchers have explored the role of serologic markers in the differentiation of central and peripheral vertigo. The study reported here was designed to evaluate the diagnostic efficacy of serologic markers (fibrinogen, D-dimer, and C-reactive protein [CRP]) in the differential diagnosis of peripheral and central vertigo. A total of 116 patients who sought treatment for vertigo at Cazi University Hospital Adult Emergency Services during a 3-mo period were included in the study. CRP, fibrinogen, and D-dimer levels were assessed in an effort to differentiate between cases of peripheral and central vertigo. In all, 65.5% of patients (76 patients) were women. Patients younger than 50 y of age accounted for 60.3% (70 patients). The average D-dimer level for the entire group of patients was 1 81.9±132.2 μg/mL, the average CRP level, 4.2±8.4 mg/L, and the average fibrinogen level, 421.9±176.0 mg/dL. Although serum D-dimer, fibrinogen, and CRP values appeared to be higher in patients with central vertigo than in those with peripheral vertigo, no statistically significant differences were noted between the 2 groups in terms of these 3 parameters (P>.05). When 6 mg/L was used as the cutoff point for CRP and 320 mg/dL was used for fibrinogen, the numbers of patients with CRP and fibrinogen levels higher than these values were significantly higher for central vertigo than for peripheral vertigo (P<.05). The present study shows that blood D-dimer, fibrinogen, and CRP levels cannot be significant markers for the differentiation of central and peripheral vertigo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Goldman B. Vertigo and dizziness. In: Tintinally JE, Kelen DG, Stapczynski JS, eds.Emergency Medicine: A Comprehensive Study Guide. 5th ed. New York: McGraw-Hill; 2000:1452–1462.

    Google Scholar 

  2. Baloh RW. Approach to the patient with dizziness. In:Dizziness, Hearing Loss and Tinnitus. 1st ed. Philadelphia, Pa: FA Davis; 1998:55–65.

    Google Scholar 

  3. Hotson JR, Baloh RW. Acute vestibular syndrome.N Engl J Med. 1998;339:680–685.

    Article  PubMed  CAS  Google Scholar 

  4. Solomon D. Distinguishing and treating causes of central vertigo.Otolaryngol Clin North Am. 2000;33:579–601.

    Article  PubMed  CAS  Google Scholar 

  5. Delaney KA. Bedside diagnosis of vertigo: value of the history and neurological examination.Acad Emerg Med. 2003;10:1388–1395.

    Article  PubMed  Google Scholar 

  6. Gizzi M, Riley E, Molinari S. The diagnostic value of imaging the patient with dizziness.Arch Neurol. 1996;53:1299–1304.

    PubMed  CAS  Google Scholar 

  7. Herr RD, Zun L, Mathews JJ. A directed approach to the dizzy patient.Ann Emerg Med. 1989; 18:664–672.

    Article  PubMed  CAS  Google Scholar 

  8. Fattori B, Nacci A, Ghilardi PL, Bruschini L, Matteucci F, Ursino F. Acute peripheral vertigo: involvement of the hemostatic system.Int Tinnitus J. 2003;9:124–129.

    PubMed  Google Scholar 

  9. Fattori B, Ursino F, Cristofani R, et al. Relevance of plasma D-dimer measurement in patients with acute peripheral vertigo.J Laryngol Otol. 2003;117:467–472.

    Article  PubMed  Google Scholar 

  10. Fattori B, Nacci A, Casani A, et al. Hemostatic alterations in patients with acute, unilateral vestibular paresis.Otolaryngol Head Neck Surg. 2001;124:401–407.

    Article  PubMed  CAS  Google Scholar 

  11. Milionis HJ, Mittari V, Exarchakos G, et al. Lipoprotein (a) and acute-phase response in patients with vestibular neuronitis.Eur J Clin Invest. 2003;33:1045–1050.

    Article  PubMed  CAS  Google Scholar 

  12. Du Clos TW. Function of C-reactive protein.Ann Med. 2000;32:274–278.

    PubMed  Google Scholar 

  13. Cook NS, Ubben D. Fibrinogen as a major risk factor in cardiovascular disease.Trends Pharmacol Sci. 1990;11:444–451.

    Article  PubMed  Google Scholar 

  14. Grau JA, Buuggle F, Becher H, et al. The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases.Thrombosis Res. 1996;82:245–255.

    Article  CAS  Google Scholar 

  15. Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack (Framingham Study).Stroke. 2001;32:2575–2579.

    Article  PubMed  CAS  Google Scholar 

  16. Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke.Stroke. 2001;32:133–138.

    PubMed  Google Scholar 

  17. Di Napoli M, Papa F. Inflammation, hemostatic markers and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients.Stroke. 2002;33:1763–1785.

    Article  PubMed  Google Scholar 

  18. Haapaniemi E, Soinne L, Syrjala M, et al. Serial changes in fibrinolysis and coagulation activation markers in acute and convalescent phase of ischemic stroke.Acta Neurol Scand. 2004;110: 242–247.

    Article  PubMed  CAS  Google Scholar 

  19. Kelly J, Rudd A, Lewis RR, et al. The relationship between acute ischaemic stroke and plasma D-dimer levels in patients developing neither venous thromboembolism nor major intercurrent illness.Blood Coagul Fibrinol. 2003;14:639–645.

    Article  CAS  Google Scholar 

  20. Tohgi H, Konno S, Takahashi S, et al. Activated coagulation/fibrinolysis system and platelet function in acute thrombotic stroke patients with increased C-reactive protein levels.Thromb Res. 2000;100:373–379.

    Article  PubMed  CAS  Google Scholar 

  21. Muir WK, Weir CJ, Alwan W, et al. C-reactive protein and outcome after ischemic stroke.Stroke. 1999;30:981–985.

    PubMed  CAS  Google Scholar 

  22. Beamer NB, Coull BM, Clark WM, et al. Persistent inflammatory response in stroke survivors.Neurology. 1998;50:1722–1728.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Emergency Medicine, Gazi University Faculty of Medicine, Besevler, 06510, Ankara, Turkey

    Emine Akinci, Gulbin Aygencel, Ayfer Keles, Ahmet Demircan & Fikret Bildik

Authors
  1. Emine Akinci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gulbin Aygencel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ayfer Keles
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ahmet Demircan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fikret Bildik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gulbin Aygencel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akinci, E., Aygencel, G., Keles, A. et al. Role of C-reactive protein, D-dimer, and fibrinogen levels in the differential diagnosis of central and peripheral vertigo. Adv Therapy 24, 1068–1077 (2007). https://doi.org/10.1007/BF02877713

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02877713

Keywords

Search

Navigation